SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Agent 6/30/05 Nymox Pharmaceutical Corp 20-F 12/31/04 5:988K Foley & Lardner/FA |
Document/Exhibit Description Pages Size 1: 20-F Annual Report HTML 945K 2: EX-12.(A) Statement re: Computation of Ratios HTML 11K 3: EX-12.(B) Statement re: Computation of Ratios HTML 11K 4: EX-13.(A) Annual or Quarterly Report to Security Holders HTML 6K 5: EX-13.(B) Annual or Quarterly Report to Security Holders HTML 6K
I, Paul Averback, President and CEO of Nymox Pharmaceutical Corporation, do hereby certify that, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the information contained in the Annual Report on Form 20-F for the year ended December 31, 2004 of Nymox Pharmaceutical Corporation and filed with the Securities and Exchange Commission, fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934 and the information contained in such report fairly presents, in all material respects, the financial condition and results of operations on Nymox Pharmaceutical Corporation
Date: June 30, 2005
/s/
Paul Averback, MD Paul Averback, MD President and Chief Executive Officer Nymox Pharmaceutical Corporation |
This ‘20-F’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 6/30/05 | 6-K | ||
For Period End: | 12/31/04 | 20-F/A, 6-K | ||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 10/27/05 SEC UPLOAD¶ 9/27/17 1:2K Nymox Pharmaceutical Corp. 8/25/05 SEC UPLOAD¶ 9/27/17 1:6K Nymox Pharmaceutical Corp. |